This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q62810995
rdf:type
wikibase:Item
schema:description
klinisch onderzoek клінічне випробування clinical trial ensayu clínicu
rdfs:label
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
skos:prefLabel
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
schema:name
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
p:P1476
wds:Q62810995-9A36F2F7-6979-43F5-A053-5E3F677FDB79
wdt:P1476
A Phase 1-2, First-in-Human Study of CX-2029 in Adults With Metastatic or Locally Advanced Unresectable Solid Tumors or Diffuse Large B-cell Lymphomas (PROCLAIM-CX-2029)
p:P582
wds:Q62810995-E97386AD-4DB9-4E29-8C41-824609B990C0
wdt:P582
2020-12-01T00:00:00Z
p:P31
wds:Q62810995-E15F2570-08EA-41A0-A402-6B8490392C74
wdt:P31
wd:Q30612
p:P580
wds:Q62810995-2B12DBE8-2B48-45EE-ACAE-9DD4408EF784
wdt:P580
2018-06-15T00:00:00Z
p:P17
wds:Q62810995-C98B4878-1DCB-4B3E-9B20-E992979CD066
wdt:P17
wd:Q30
p:P921
wds:Q62810995-E707FE00-BC44-493B-BEB6-D50AC020FA8B
wdt:P921
wd:Q12078
p:P6153
wds:Q62810995-28CE56A5-FC9A-4989-B183-C43EC8F6F841 wds:Q62810995-00930A2A-8E2B-42D4-9B69-45DEE3C6B127 wds:Q62810995-84295482-A635-46A1-B632-4BA8876D340B wds:Q62810995-E05FE713-66A3-47E6-BD0D-93275C0DCA85
wdt:P6153
wd:Q30270369 wd:Q131252 wd:Q4614 wd:Q4858714
p:P2899
wds:Q62810995-D01355B9-3754-4209-B917-DDC886578B01
wdt:P2899
18
p:P1050
wds:Q62810995-061836C9-AEAD-4313-965D-30F4C65B74D9
p:P859
wds:Q62810995-D227A689-0280-4CE6-AE78-EDBB5ABB7E66
wdt:P1050
wd:Q208414
wdt:P859
wd:Q30265385
p:P1132
wds:Q62810995-0ECE58DD-B3D3-4E35-9326-5A8EA67285A7
wdt:P1132
150
p:P8363
wds:Q62810995-8918FFAA-5097-4908-A014-DDA57720F562
wdt:P8363
wd:Q78089383
p:P3098
wds:Q62810995-8C6B6297-9BFD-4D4A-8B37-7DF5C2AA3AEA
wdt:P3098
NCT03543813
p:P6099
wds:Q62810995-14716E29-9A55-40F5-9051-59E93235C096 wds:Q62810995-4B6CA131-51B1-4BF7-AE7C-0BD54D652B74
wdt:P6099
wd:Q5452194 wd:Q42824440
p:P8005
wds:Q62810995-88109106-4C77-4B40-8A68-ED974F055F1F
wdt:P8005
wd:Q76649708